HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dysprosium-enhanced MR imaging for tumor tissue characterization. An experimental study in a human xenograft model.

AbstractPURPOSE:
To evaluate dysprosium-enhanced MR imaging for differentiation between morphologically intact and necrotic tumor tissue in a tumor model.
MATERIAL AND METHODS:
A human colon carcinoma was transplanted subcutaneously into 9 nude (immunodeprived) rats. MR imaging was performed before and after injection of the dysprosium agent Dy-DTPA-BMA. T1-, T2- and T2*-weighted sequences were acquired. The tumors were dissected, histological sections were prepared, and compared with corresponding MR images.
RESULTS:
In intact tissue, the MR signal intensity in the T2- and T2*-weighted images decreased after Dy injection and the delineation of the intact regions were sharp and corresponded well to the gross histological sections.
CONCLUSION:
Dy-enhanced MR imaging facilitated the differentiation between intact and necrotic tumor tissue.
AuthorsC Wang, A Sundin, A Ericsson, T Bach-Gansmo, A Hemmingsson, H Ahlström
JournalActa radiologica (Stockholm, Sweden : 1987) (Acta Radiol) Vol. 38 Issue 2 Pg. 281-6 (Mar 1997) ISSN: 0284-1851 [Print] England
PMID9093166 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Contrast Media
  • Dysprosium
Topics
  • Adenocarcinoma (diagnosis)
  • Animals
  • Colonic Neoplasms (diagnosis)
  • Contrast Media
  • Dysprosium
  • Humans
  • Magnetic Resonance Imaging (methods)
  • Male
  • Necrosis
  • Neoplasm Transplantation
  • Rats
  • Rats, Nude
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: